PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2023-05-02

Date Title Company
02-May-2023 Defibrillator Market Updates 2023: Predicted to Grow at CAGR of 6.6% by 2030, Report The Wire Times
02-May-2023 Rapid Dose Announces Revocation of Cease Trade Order Businesswire
02-May-2023 Harrow Launches ILEVRO®, NEVANAC®, and MAXIDEX® in the U.S. Businesswire
02-May-2023 Anavo Therapeutics extends Seed Round to EUR 28 Million to Advance Pipeline of Novel Phosphatase Modulators Toward the Clinic Businesswire
02-May-2023 D&D Pharmatech Announces Rapid, Clinically Significant Reductions in Liver Fat Achieved in Four Weeks Treating NAFLD Patients with DD01, a Novel Long-Acting GLP-1/Glucagon Receptor Agonist Businesswire
02-May-2023 Precision BioSciences to Report First Quarter 2023 Results on May 9, 2023 Businesswire
02-May-2023 Inhibition of Pancreatic Cancer by Namodenoson: Molecular Mechanism of Action Discovered by Can-Fite Scientists Businesswire
02-May-2023 Politan Nominates Two Candidates for Masimo Board Businesswire
02-May-2023 Filing of Form S-4 and Mailing of Definitive Proxy Statement by Rosecliff Acquisition Corp. I Spectral MD Holdings, Ltd
02-May-2023 Pfizer Reports First-Quarter 2023 Results Businesswire
02-May-2023 Envirotainer and American Airlines take a key step in improving global access of vital medicines Envirotainer
02-May-2023 Amolyt Pharma Announces Phase 3 Clinical Trial of Eneboparatide for the Treatment of Hypoparathyroidism following Positive End of Phase 2 Meeting with FDA Amolyt Pharma
02-May-2023 Aurion Biotech to Present Clinical Trial Results at the 2023 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting Businesswire
02-May-2023 CPHI & PMEC China 2023 to see surge from pent up international ingredients demand CPHI
02-May-2023 AmerisourceBergen Reports Fiscal 2023 Second Quarter Results Businesswire
02-May-2023 KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Businesswire
02-May-2023 Stevanato Group to Present at BofA Securities Healthcare Conference Businesswire
02-May-2023 Gloves Market 2023 Trends: Technical Points Signs to Grow at a CAGR of 8.6%, Claims AMR The Wire Times
02-May-2023 Almirall: Up to 73% of Atopic Dermatitis Patients Taking Lebrikizumab Had Improved or Cleared Skin on Face or Hands in New Analysis Almirall
02-May-2023 Tay Therapeutics Announces Licensing to VYNE Therapeutics of Oral BET Inhibitor for immuno-inflammatory and fibrotic disorders Tay Therapeutics